Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

arcoris bio AG

History from 14 Feb 2022

UID
CHE-192.823.524
Legal form
AG
Canton
ZH
Founded
14 Feb 2022
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 176k
44k88k132k176k17 Jul 2023 · CHF 117k23 Apr 2024 · CHF 129k10 Sep 2025 · CHF 176k20242025
  • shares

Record

  1. Company formed

    Founded 14 Feb 2022

    SHAB HR01-1005407967 ↗
  2. Capital band adopted

    SHAB HR02-1005677740 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 117’389
    Shares
    100’000 → 117’389
    New shares, % of post-step shares
    14.8% (17’389 new)

    Aktienkapital neu: CHF 117'389.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 117'389.00 [bisher: CHF 100'000.00]. Aktien neu: 117'389 vinkulierte Namenaktien zu CHF 1.00 [bisher: 100'000 vinkulierte Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005796788 ↗
  4. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    117’389 → 129’152
    Shares
    117’389 → 129’152
    New shares, % of post-step shares
    9.1% (11’763 new)

    Aktienkapital neu: CHF 129'152.00 [bisher: CHF 117'389.00]. Liberierung Aktienkapital neu: CHF 129'152.00 [bisher: CHF 117'389.00]. Aktien neu: 129'152 vinkulierte Namenaktien zu CHF 1.00 [bisher: 117'389 vinkulierte Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006015443 ↗
  5. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    129’152 → 176’225
    Shares
    129’152 → 176’225
    New shares, % of post-step shares
    26.7% (47’073 new)

    Aktienkapital neu: CHF 176'225.00 [bisher: CHF 129'152.00]. Liberierung Aktienkapital neu: CHF 176'225.00 [bisher: CHF 129'152.00]. Aktien neu: 176'225 Namenaktien zu CHF 1.00 [bisher: 129'152 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 03.09.2025 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen. [bisher: Kapitalband gemäss näherer Umschreibung in den Statuten.].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006429133 ↗
  6. Capital band adopted

    SHAB HR02-1006429133 ↗

Published by 14 Sep 2025

Latest available record · 8 Oct 2026